Of note, CA27.29 (See Table 2), another mucin marker associated with the gene (Mucin 1) is a slightly more sensitive breast cancer marker than CA15-3 and so the FDA has approved both cancer antigens for monitoring therapy in recurrent or advance breast cancer [96]. Here, MUC1 is linked to breast carcinoma.